Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality

Hebart, H Brugger, W Grigoleit, U Gscheidle, B Loeffler, J Schafer, H Kanz, L Einsele, H Sinzger, C

H. Hebart et al., Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality, BLOOD, 97(7), 2001, pp. 2183-2185

9

Hematology,"Cardiovascular & Hematology Research

BLOOD

00064971 → ACNP

97

7

2001

2183 - 2185

ISI

0006-4971(20010401)97:7<2183:RFCDIP>2.0.ZU;2-#